Myrox^®

Myrox ® is a preparation of Ambroxol Hydrochloride. It possesses both expectorant & mucolytic effects. It dilutes the thick mucus in the respiration track and facilitates excretion of it. It also increases bronchial secretion and decreases viscosity to make coughs more productive. Long-term use is possible because of good tolerability of the preparation.

No Data

Myrox ® is indicated in

• Productive cough
• Acute and chronic inflammatory disorders of upper and lower respiratory tract associated with viscous mucus including acute and chronic bronchitis.
• Inflammatory diseases of rhino-pharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus.
• Asthmatic bronchitis, bronchial asthma with thick expectoration.
• Bronchiectasis
• Chronic pneumonia

Myrox ® SR Capsule:
Adults and children over 12 years old: 1 capsule daily.

Myrox ® Syrup:
Adult: 10ml 3 times daily.
Children 2-6 years: ½ teaspoonful 2 to 3 times daily.
Children 6-12 years: 1 teaspoonful 2 to 3 times daily.

Myrox ® Pediatric Drops:
Children 0-6 months: 0.5ml 2 times daily.
Children 6-12 months: 1ml 2 times daily.
Children 12-24 months: 1.5ml 2 times daily

Myrox ® (ambroxol) should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnantwomen with ambroxol. Special care is recommended during pregnancy, especially during the first 3 months of pregnancy. It is not known whether ambroxol is secreted in human milk. Because many drugs are excreted in human milk, Myrox ® should not be administered to a breastfeeding woman.

No Data

Caution is necessary when bronchomotoric function is impaired. Patients with hepatic and renal insufficiency should take it with caution. Ambroxol should not be given with cough suppressants, as a dangerous increase of bronchial secretion occur. Ambroxol should be given with care to patients suffering from peptic ulcer.

Headache, nausea, gastrointestinal troubles are only seldom reported.

Contraindicated in ascertained hypersensitivity to Ambroxol.

Ambroxol has no interaction with cardioactive glycosides, corticosteroids, bronchodilators, diuretics and antibiotics normally used in the treatment of bronchopulmonary infections.

No Data

No Data

Store in a cool, dry place. Protect from light.